A carregar...

Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations

PURPOSE: There is persistent controversy as to whether EGFR/KRAS mutations occur in pulmonary squamous cell carcinoma (SQCC). We hypothesized that the reported variability may reflect difficulties in the pathologic distinction of true SQCC from adenosquamous carcinoma (AD-SQC) and poorly-differentia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rekhtman, Natasha, Paik, Paul K., Arcila, Maria E., Tafe, Laura J., Oxnard, Geoffrey R., Moreira, Andre L., Travis, William D., Zakowski, Maureen F., Kris, Mark G., Ladanyi, Marc
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3487403/
https://ncbi.nlm.nih.gov/pubmed/22228640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!